Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Laggner

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Chemmedchem|March 17, 2009
Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphataseRosanna Maccari, Rosaria Ottanà, Rosella Ciurleo, et al.
Biochimie|July 31, 2013
Carbamoylation abrogates the antioxidant potential of hydrogen sulfideMonika Praschberger, Marcela Hermann, Christian Laggner, et al.
Bioorganic & Medicinal Chemistry|March 20, 2009
Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitorsMarco Forghieri, Christian Laggner, Paolo Paoli, et al.
Journal of Medicinal Chemistry|February 13, 2008
Structure-activity relationship of S-trityl-L-cysteine analogues as inhibitors of the human mitotic kinesin Eg5Salvatore Debonis, Dimitrios A Skoufias, Rose-Laure Indorato, et al.
Bioorganic & Medicinal Chemistry|February 17, 2009
5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitorsRosaria Ottanà, Rosanna Maccari, Rosella Ciurleo, et al.
Journal of Medicinal Chemistry|July 22, 2005
Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screeningChristian Laggner, Claudia Schieferer, Birgit Fiechtner, et al.
International Journal of Molecular Sciences|December 17, 2024
Discovery of a Small Molecule with an Inhibitory Role for RAB11Camille Lempicki, Julian Milosavljevic, Christian Laggner, et al.
Chemmedchem|August 26, 2010
Structure-activity relationships and molecular docking of novel dihydropyrimidine-based mitotic Eg5 inhibitorsHana Prokopcová, Doris Dallinger, Georg Uray, et al.
Journal of Computer-Aided Molecular Design|August 2, 2007
Generation of a homology model of the human histamine H(3) receptor for ligand docking and pharmacophore-based screeningBirgit Schlegel, Christian Laggner, Rene Meier, et al.
Journal of Medicinal Chemistry|February 25, 2011
Structure-activity relationship and multidrug resistance study of new S-trityl-L-cysteine derivatives as inhibitors of Eg5Hung Yi Kristal Kaan, Johanna Weiss, Dominik Menger, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Chemmedchem|March 17, 2009
Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphataseRosanna Maccari, Rosaria Ottanà, Rosella Ciurleo, et al.
Biochimie|July 31, 2013
Carbamoylation abrogates the antioxidant potential of hydrogen sulfideMonika Praschberger, Marcela Hermann, Christian Laggner, et al.
Bioorganic & Medicinal Chemistry|March 20, 2009
Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitorsMarco Forghieri, Christian Laggner, Paolo Paoli, et al.
Journal of Medicinal Chemistry|February 13, 2008
Structure-activity relationship of S-trityl-L-cysteine analogues as inhibitors of the human mitotic kinesin Eg5Salvatore Debonis, Dimitrios A Skoufias, Rose-Laure Indorato, et al.
Bioorganic & Medicinal Chemistry|February 17, 2009
5-Arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitorsRosaria Ottanà, Rosanna Maccari, Rosella Ciurleo, et al.
Journal of Medicinal Chemistry|July 22, 2005
Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screeningChristian Laggner, Claudia Schieferer, Birgit Fiechtner, et al.
International Journal of Molecular Sciences|December 17, 2024
Discovery of a Small Molecule with an Inhibitory Role for RAB11Camille Lempicki, Julian Milosavljevic, Christian Laggner, et al.
Chemmedchem|August 26, 2010
Structure-activity relationships and molecular docking of novel dihydropyrimidine-based mitotic Eg5 inhibitorsHana Prokopcová, Doris Dallinger, Georg Uray, et al.
Journal of Computer-Aided Molecular Design|August 2, 2007
Generation of a homology model of the human histamine H(3) receptor for ligand docking and pharmacophore-based screeningBirgit Schlegel, Christian Laggner, Rene Meier, et al.
Journal of Medicinal Chemistry|February 25, 2011
Structure-activity relationship and multidrug resistance study of new S-trityl-L-cysteine derivatives as inhibitors of Eg5Hung Yi Kristal Kaan, Johanna Weiss, Dominik Menger, et al.
Pageof 5